Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Pharma Asia
Pharma
China's Big Pharma dream meets US crackdown—Fierce Pharma Asia
Chinese companies want to become Big Pharma. Experts warn that the U.S. Treasury's proposed ban on certain U.S. investments in China could backfire.
Angus Liu
Nov 13, 2026 8:38am
Boehringer-SBP, Fresenius-WuXi Bio, Evommune—Fierce Pharma Asia
Nov 6, 2026 8:04am
Enhertu successor, ESMO, Gilead—Fierce Pharma Asia
Oct 30, 2026 8:45am
COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia
Oct 23, 2026 8:42am
Roche, Asahi Kasei, Verastem—Fierce Pharma Asia
Oct 16, 2026 7:57am
Novartis, Shionogi, ArriVent—Fierce Pharma Asia
Oct 9, 2026 8:30am
